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INTRODUCTION
Pleomorphic adenoma (PA) is the most common benign tumor
of the salivary gland that comprises 70% of all salivary gland
tumors. This very common tumor has a unique property that is
not common to other benign tumors. Almost all PAs have focally
thin capsules and 25% of all PAs demonstrate satellite nodules or
pseudopodia (1). Since uncontrolled growth with invasion into
adjacent tissue is a feature of the malignant tumor, the invasive
characteristic of PA is quite interesting. Generally, the surgical
technique is blamed for the recurrence of PA in the parotid gland.
This may be partially true, but there are some reports suggesting
that the invasive characteristic of the tumor cells also has a roll
in recurrence (2-4).
The incidence of recurrence is 0-17% (5-7). Given that an ap-
propriate operation has been performed, the recurrence rate is
reported to be 2-5% (8). Compared with primary PA, a more
judicious approach is required for recurrent pleomorphic adeno-
ma (RPA) of the parotid gland for several reasons. RPA is diffi-
cult to operate on and the risk of facial nerve damage is higher.
RPA often has multicentric lesions and is sometimes associated
with malignant transformation (MT). The possibility of MT in RPA
is reported to range from <10 to 40% (5). Considering that RPA
is still a benign mass, multinodular change and higher chance of
malignant transformation require a more complete explanation,
other than just poor surgical technique.
Although many articles have addressed primary PA of the pa-
Objectives. This study was undertaken to confirm the clinical characteristics of recurrent pleomorphic adenoma (RPA),
and to identify those factors that affect the development of malignant transformation (MT) from RPA.
Methods. The medical records of 270 patients, who were operated upon for parotid PA, were retrospectively reviewed.
The pathologic specimens of a selected series of 23 patients were reviewed for histologic subtype and microscopic
multi-nodularity.
Results. Mean age of initial operation in RPA without MT (RPA
-MT) group was significantly lower than that of primary PA
group. Mean age of the revision operation in RPA with MT (RPA
+MT) group was significantly greater than that of
RPA
-MT group. Mean interval from operation to recurrence shortened after each revision operation. The risk of MT
and additional recurrence increased significantly with recurrence. In RPA
-MT group tumor recurrence occurred in
21.4% of patients despite a clear resection margin.
Conclusion. The risk factors for MT may be an age of over 45 yr and multiple recurrences. However, younger patients
are more at risk of recurrence. A clear resection margin cannot guarantee a cure in RPA, and it seems that parotid
pleomorphic adenomas slowly gain malignant characteristics after repeated recurrences.
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jective of the present study was to review the clinical manifesta-
tions of RPA and to identify those factors that affect the devel-
opment of MT from RPA.
MATERIALS AND METHODS
Review of medical records
From January 1984 through December 2004, 270 patients diag-
nosed with PA or carcinoma ex PA of the parotid gland, and who
had undergone an operation at the Department of Otorhinolar-
yngology, Seoul National University Hospital were included in
this study. Medical records were retrospectively reviewed. The
mean follow-up period was 108.1±79.5 months for the parotid
PA patients. At initial operation, 252 patients were diagnosed
as having parotid PA and 18 patients were diagnosed as having
carcinoma ex PA. Of the 252 PA patients, 232 had no evidence
of recurrence after the initial operation; these patients are referred
to as the primary PA group. PA recurred in the remaining 20
patients (the RPA group). This group was further subdivided into
two patient groups, i.e., those in whom PA remained benign (the
RPA
-MT group) and those who later developed MT (the RPA
+MT
group). The RPA
-MT group was composed of 15 patients who un-
derwent a total of 19 revision operations, and the RPA
+MT group
was composed of five patients who underwent a total of eight
revision operations. Of the 20 patients in the RPA group, 14 were
referred to us after an initial operation in another hospital, and
six underwent a first operation at our institute.
Operations of the parotid gland were classified into five types:
enucleation, excision, superficial parotidectomy, total parotidec-
tomy and wide resection. Enucleation was defined as mass re-
moval involving the dissection of the supracapsular plane with
no resection margin, whereas excision was defined as leaving a
few millimeters of resection margin to preserve the tumor cap-
sule. Superficial parotidectomy was defined as complete super-
ficial lobe removal and partial superficial lobe removal. Total
parotidectomy was defined as total removal of the parotid gland
and partial removal of the deep lobe with resection of the super-
ficial lobe. Wide resection was defined as excision of the mass
and limited neck dissection of level II neck nodes.
Review of pathologic specimens 
Twelve pathologic specimens were available for histological re-
view in the RPA
-MT group. Eleven pathologic specimens were
selected from age- and sex-matched patients in the primary PA
group. No pathologic specimens were available for histological
review in the RPA
+MT group.
Histologic subtype was determined according to Seifert’s clas-
sification (9). This classification is based on the proportions of
stromal and cellular components. In type 1, 30-50% of the tumor
mass is composed of stroma, and in type 2 this increases to >80%.
On the other hand, type 3 is rich in cells (>80%) but poor in
stroma, and type 4, like type 3, is also rich in cells and poor in
stroma, but differs from type 3 because the epithelial component
is uniformly differentiated. Indeed, type 4 resembles monomor-
phic adenoma.
The nodularities of these 23 specimens were also checked, and
specimens were categorized as being of the single nodular type
or the multi-nodular type based on its microscopic findings. A
multi-nodular type was defined as a tumor with one or more satel-
lite nodules beyond the mother nodule capsule, and the single no-
dular type was defined as a tumor without any satellite nodules.
Statistical analysis was performed using the Student’s T, Mann-
Whitney U, and Pearson’s chi-square tests in SPSS ver. 12.0 (SPSS
Inc., Chicago, IL, USA). P-values of <0.05 were considered sig-
nificant.
RESULTS
Sex and age of patients
Sex ratios (male:female) were 76:156 in the primary PA group,
6:9 in the RPA
-MT group and 3:2 in the RPA
+MT group. The ratios
were not significantly different. Mean age at initial operation was
40.0±13.8 in the primary PA group. Mean ages at revision oper-
ations were 30.4±9.3 in the RPA
-MT group and 49.2±18.2 in the
RPA
+MT group. The mean age of the RPA
-MT group was signifi-
cantly lower than that of the primary PA group (P<0.01). In addi-
tion, mean age at initial operation in the RPA
-MT group was 21.9
±8.5 yr, which was also significantly less than that of patients
in the primary PA group (P<0.01). The mean age in the RPA
+MT
group was significantly greater than in the RPA
-MT group (P=0.02).
A significant difference was found in the distribution of patients
with MT when the RPA patient group was dichotomized about
45-yr age (P<0.01).
Types of operation
Details of the initial operations are listed in Table 1. Incidences
of recurrence were 66.7% (8/12) for enucleation and excision,
1.9% (4/214) for superficial parotidectomy, and 21.7% (5/23)
for total parotidectomy. Enucleation and excision were associ-
ated with a significantly higher possibility of recurrence compared
to superficial parotidectomy (P<0.01), given that the tumor sizes
and locations were similar.
Details of subsequent operations due to recurrence are listed
in Table 2. Because the majority of patients in the RPA
+MT group
had already undergone total parotidectomy during the initial
operation, recurrence was mainly managed by excision or wide
resection.
Resection margins and surgical outcomes
Unfortunately, we were unable to check resection margins at
initial operations in the RPA group, because the majority of the
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er institute prior to their referral. As for the revision operations,
in the RPA
-MT group a clear resection margin was obtained in 14
(73.7%) revision operations, resection margins showed tumor
involvement in four (21.1%) revision operations, and informa-
tion was not available for one. Of these 14 revision operations
with a clear resection margin, three (21.4%) later re-recurred. Of
the four patients with a positive resection margin, two (50.0%)
underwent adjuvant radiation therapy and have remained dis-
ease free for 9 and 92 months, respectively. One patient devel-
oped recurrence but follow-up was not possible, and the other
patient who underwent an additional resection remained disease
free at 84 months postoperatively. In the RPA
+MT group a clear
resection margin was obtained in five of the eight revision oper-
ations (62.5%). However, only one (20%) of the five did not
recur (over a 9 month follow-up), and the four (80%) remain-
ing patients expired due to the disease, despite a clear resection
margin. All of the patients with a positive resection margin ex-
pired due to the disease.
Time to recurrence
Times between operation and recurrence were evaluated. The
average times from operation to succeeding recurrence after oper-
ations 1-4 were 51.4, 27.5, 19.0, and 5.8 months, respectively
(Fig. 1), which represented decreasing tendency after subsequent
revisions. But the statistical significance was marginal (P=0.06).
Percentage malignancy
Percentage malignancies among previously benign PA patients
at operations 1-5 were 6.7% (18/270), 15.0% (3/20), 14.3%
(1/7), 0.0% (0/2), and 50.0% (1/2), respectively (Fig. 1), which
represented a significant increasing trend (P=0.04).
Possibility of additional recurrence
Additional recurrences in patients with benign PA after the oper-
ations 1-4 were 2.5% (6/252), 41.2% (7/17), 33.3% (2/6) and
100.0% (2/2), respectively (Fig. 1). A general trend was observed
toward a higher possibility of recurrence after repeated opera-
tions (P<0.01). 
Histologic subtype and nodularity
PA histologic subtypes were reviewed in the primary PA group
and in the RPA
-MT group. Results are presented in Table 3. No
significant subtype distribution differences were observed be-
tween these two groups (P=0.57). As for nodularity, whereas
only 45.5% (5/11) specimens were multi-nodular in the prima-
Suh M-W et al.: Recurrent Pleomorphic Adenoma 195
Group Type of operation No. (%)
Table 1. Types of initial operation
*Enucleation and excision are no longer performed at our institute. The ma-
jority of cases that underwent initial enucleation were referred by another
institute after recurrence.
PA: pleomorphic adenoma; RPA: recurrent pleomorphic adenoma; MT: ma-
lignant transformation; RPA
-MT group: group of patients in whom recurrent
pleomorphic adenoma remained benign; RPA
+MT group: group of recurrent
pleomorphic adenoma patients who later developed MT.
Primary PA (n=232) Excision* 4 (1.7)
Superficial parotidectomy 210 (90.5)
Total parotidectomy 18 (7.8)
RPA
-MT (n=15) Enucleation* 6 (40.0)
Superficial parotidectomy 4 (26.7)
Total parotidectomy 2 (13.3)
Record not available 3 (20.0)
RPA
+MT (n=5) Enucleation* 2 (40.0)
Total parotidectomy 3 (60.0)
Group Type of operation No. (%)
Table 2. Operations performed to manage recurrent pleomorphic
adenoma
Nop: number of operations; RPA: recurrent pleomorphic adenoma; MT:
malignant transformation; RPA
-MT group: group of patients in whom recur-
rent pleomorphic adenoma remained benign; RPA
+MT group: group of
recurrent pleomorphic adenoma patients who later developed MT.
RPA
-MT (Nop=19) Excision 5 (26.3)
Superficial parotidectomy 6 (31.6)
Total parotidectomy 6 (31.6)
Wide resection with neck dissection 2 (10.5)
RPA
+MT (Nop=8) Excision 3 (37.5)
Total parotidectomy 2 (25.0)
Wide resection 2 (25.0)
Wide resection with subtotal 1 (12.5)
temporal bone resection
Fig. 1. Progressive changes in clinical manifestations after multiple
recurrences. 
Duration between revision operations and subsequent recurrences
tended to shorten as the number of previous revisions increased (P=
0.06). The percentage of patients with a malignant tumor at revision
surgery was higher than at initial operation (P=0.04). The general
trend toward an increased risk of further recurrence after repeated
surgery was significant (P<0.01), despite our finding of a lower risk
at the third than at the second operation.
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the RPA group (P=0.03).
DISCUSSION
Although the knowledge of “pseudopods” and the introduction
of “superficial parotidectomy” have greatly reduced the incidence
of recurrence from 40% to <5% (10, 11) several questions re-
main unanswered about the manifestations of RPA, such as those
concerning multi-nodular change and nodular infiltration into
normal parotid tissue after recurrence (8). Until now, the rup-
ture or spillage of tumor cells has seemed like a good explana-
tion, but recent reports have suggested that there is no relation-
ship between rupture and recurrence (12-14). Intriguingly, sev-
eral studies have also reported that recurrence is more frequent
in those treated by formal parotidectomy rather than in those
that have undergone simple excision (15, 16). Distant metasta-
sis of this benign tumor has also been reported on several occa-
sions (17, 18). A new concept is needed to overcome these dis-
cordances. One suggestion made was that the biology of tumor
cells might in part determine the development of recurrence and
the multi-nodular appearances of masses. That is, PA tumor cells
might adopt a more aggressive phenotype after recurrence (3, 19).
Age is related with recurrence and MT
On comparing the mean ages of the study groups, it was notice-
able that patients in the RPA
-MT group were significantly you-
nger than in the primary PA group. There are several possible
explanations for this observation, i.e., PAs in younger patients
may be more aggressive than that in older patients (20), alter-
natively, as younger patients have a longer life span they are at
greater risk of recurrence. However, in the present study, both
age at revision operation (30.4±9.3 yr) and age at initial oper-
ation (21.9±8.5 yr) in the RPA
-MT group were significantly
lower than that in the primary PA group (40.0±13.8 yr). There-
fore, it may not be true that a band of patients in the primary
PA group, who have under gone an incomplete operation, will
later turn into a member of the RPA
-MT group. The characteris-
tics of tumors in these two groups may be intrinsically different.
It was also noticeable that older patients had a higher proba-
bility of developing MT, as a significant difference was found in
the distribution of patients with MT when the RPA patient
group was dichotomized about 45 yr of age.
A clear resection margin may not guarantee a cure
Although RPA is generally considered a benign tumor, in the
present study a clear resection margin was not found to guarantee
cure, because in our RPA
-MT group tumor recurrence occurred in
21.4% of patients despite a clear resection margin. Moreover,
in the RPA
+MT group, resection margins were found to be even
less reliable, because tumors recurred in 80.0% of patients with
margins found to be clear. Thus, even though RPA is considered
a benign disease, surgeons should not rely wholly on pathologic
conclusions concerning resection margins, and patients should
be followed regularly after revision surgery.
Tumors may became progressively more aggressive
after multiple recurrences
As Fig. 1 shows, time from operation until the next recurrence
was reduced after repeated recurrences. The mean time to first
recurrence was 51.4 months and that to second recurrence was
27.5 months. These results concur with those of Fee et al. (21),
who found mean times to first recurrence of 5-7 yr and to sec-
ond recurrence of 2-5 yr. In addition, in the present study, the
likelihood of MT after repeated recurrence and likelihood of a
subsequent recurrence also increased significantly with opera-
tion number. These results reveal that tumors become more
aggressive after repeated recurrence.
RPA are more multi-nodular than is evident by
intraoperative gross inspection
In terms of nodularity, 91.7% of RPAs were found to be multi-
nodular under the light microscope, but previous intraoperative
visual inspection findings place the figure at 44-67% (22, 23).
Our findings indicate that although RPAs may appear to be sin-
gle masses by gross inspection, the majority are microscopically
multi-nodular with satellite nodules. Importantly, this finding
provides good evidence supporting a wide resection approach,
even for RPAs with an innocuous appearance. 
In terms of Seifert’s histologic subtypes, several reports have
concluded that recurrence is higher for the type 2 subtype (9, 24,
25). According to these reports, 61% of RPA cases were of the
type 2 subtype (25). However, in the present study, we were un-
able to find a significant difference between the primary PA and
RPA groups with respect to subtype proportions, and the study
by Fee et al. (21) also concurs with our findings. Thus, because of
the above discrepancies it is difficult to give an overview of the
relationship between recurrence and histologic subtype for now.
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Group Histologic subtype No. (%)
Table 3. Histologic subtypes of pleomorphic adenomas
PA: pleomorphic adenoma; RPA: recurrent pleomorphic adenoma; MT:
malignant transformation; RPA
-MT group: group of patients in whom recur-
rent pleomorphic adenoma remained benign.
Primary PA (n=11) Type 1 5 (45.5)
Type 2 2 (18.2)
Type 3 4 (36.4)
Type 4 0 (0.0)
RPA
-MT (n=12) Type 1 8 (66.7)
Type 2 1 (8.3)
Type 3 3 (25.0)
Type 4 0 (0.0)The results of this study indicate that RPA lies somewhere be-
tween a benign and malignant disease. Poor surgical technique
has been generally blamed for recurrence, but the inherent nature
of this tumor probably plays an important role even in the ini-
tial operation as well as the revision operation. For example, a
more meticulous resection is required in younger patients since
the nature of PAs in younger patients may be more aggressive
than that in older patients. Based on our findings, the risk factors
for MT seems to be an age of more than 45 yr and multiple recur-
rences. Also, it should be born in mind that tumors may become
progressively more aggressive after multiple recurrences, and
that RPA are much more multi-nodular to a great extent than is
evident by intraoperative gross inspection.
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